Is Colfax Corp Headed for a Breakout?

NYSE: CFX | Colfax Corporation  News, Ratings, and Charts

CFX – A resistance level has formed in the chart of Colfax Corporation (CFX). The stock has been struggling to break through this level, but if it does, a breakout is expected. Read more to learn how to take advantage of this trading opportunity.

Colfax Corporation (CFX) is a diversified technology firm that produces welding equipment and medical devices. Its fabrication technology unit is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications.

Its medical technology segment makes medical devices, including orthopedic braces, reconstructive implants, and other products used for rehabilitation, physical therapy, and pain management.

The company is benefiting from its focus on product innovation, a healthy business system, and its cost-cutting initiatives. This led to a strong quarter, where CFX outpaced both its earnings and sales estimates. CFA has a current ratio of 1.6, which indicates it has more than enough liquidity to handle short-term debt.

In terms of growth, its EBITDA has grown an average of 48% a year over the past three years. Plus, analysts forecast earnings to rise 34.1% year over year in the current quarter. This has led to a Growth Grade of A in our POWR Ratings system.

Based on its forward P/E of 21.41, its stock appears a tad overvalued. The stock showed bullish momentum from November to March, but performance has been mixed since, as shown in the chart below.

Take a look at the 1-year chart of CFX below with added notations:

 Chart of CFX provided by TradingView

After a steady rally up into its March peak, CFX has struggled to get past the $50 resistance (red) area. That level is also preventing the stock from hitting new 52-week highs. CFX has dropped back again, but traders should watch for a possible return to the high.

Click Here to Read the Greatest Trading Book Ever Written

The ideal long position on the stock would be on a breakout above the $50 level, with a protective stop placed below the entry point.

Want to Discover More Great Trades?

What is better than finding the 1 attractive stock in this article?

Discovering 5 timely trades…like the ones in this new special report. Click below to claim your free copy now!

5 Stocks Ready to BREAKOUT!


CFX shares were unchanged in premarket trading Tuesday. Year-to-date, CFX has gained 23.35%, versus a 20.46% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp


I am an expert stock market coach having helped over 4000 beginner and advanced traders & investors from around the world take control of their financial futures. I also write stock market related articles for the Adam Mesh Trading Group and Yolo Publishing. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CFXGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Investor Alert: “Buy the Rumor, Sell the News!”

Everyone knows that the Fed is going to cut rates at some point this year. That is the worst kept secret on the planet helping to explain how we keep making new highs for the for the S&P 500 (SPY). Unfortunately that creates an interesting predicament for stocks after rates are cut. Plus another hurdle in the 2024 Presidential election. Steve Reitmeister is here to share his insights on the market outlook along with a preview of his top 12 stocks to outperform. Read on for more...

Read More Stories

More Colfax Corporation (CFX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CFX News